Patient Guide: Retrospective-prospective Study to Evaluate Treatment Management and Outcomes of Patients With Waldenström's Macroglobulinemia (WM) Treated in Italy According to the Zanubrutinib (Brukinsa®) Compassionate Use Program (CUP) and in Common Practice Following Commercial Approval.

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 28 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT06441214
Status: 🟢 Enrolling Now
Condition: Waldenström's Macroglobulinemia (WM)
Phase: Research Study

Find a Study Location Near You

This study is available at 28 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Alessandria,
  • Ancona,
  • Ascoli Piceno,
  • • And 25 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily